COVID-19 vaccine registry for pregnant women: policy to control complications of vaccination in pregnant women in 2021-2022.
COVID-19 vaccines
Pregnancy
Registry
Vaccination
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
27 Jul 2023
27 Jul 2023
Historique:
received:
12
03
2023
accepted:
15
07
2023
medline:
31
7
2023
pubmed:
28
7
2023
entrez:
27
7
2023
Statut:
epublish
Résumé
Data management related to COVID-19 vaccination in pregnant women is vital to improve the treatment process and to establish preventive programs. Implementing a registry to manage data is an essential part of this process. This study aims to design a national model of the COVID-19 vaccination registry for pregnant women in Iran. The present study is an applied descriptive study conducted in 2021 and 2022 in two stages. In the first stage, the coordinates of the National Registry of COVID-19 vaccination of pregnant women from related references and articles, as well as the comparative study of the National Registry of COVID-19 vaccination of pregnant women in the United States, Canada, and the United Kingdom was done. In the second stage, the preliminary model was designed. The model was validated using the Delphi technique and questionnaire tools and analyzing the data. The presented national COVID-19 vaccination registry model of pregnant women's main components consist of objectives, data sources, structure, minimum data set, standards, and registry processes, all of which received 100% expert consensus. The vaccination registry of pregnant women has a major role in managing COVID-19 vaccination data of pregnant women and can be one of the Ministry of Health and Medical Education priorities.
Sections du résumé
BACKGROUND
BACKGROUND
Data management related to COVID-19 vaccination in pregnant women is vital to improve the treatment process and to establish preventive programs. Implementing a registry to manage data is an essential part of this process. This study aims to design a national model of the COVID-19 vaccination registry for pregnant women in Iran.
METHODS
METHODS
The present study is an applied descriptive study conducted in 2021 and 2022 in two stages. In the first stage, the coordinates of the National Registry of COVID-19 vaccination of pregnant women from related references and articles, as well as the comparative study of the National Registry of COVID-19 vaccination of pregnant women in the United States, Canada, and the United Kingdom was done. In the second stage, the preliminary model was designed. The model was validated using the Delphi technique and questionnaire tools and analyzing the data.
RESULTS
RESULTS
The presented national COVID-19 vaccination registry model of pregnant women's main components consist of objectives, data sources, structure, minimum data set, standards, and registry processes, all of which received 100% expert consensus.
CONCLUSION
CONCLUSIONS
The vaccination registry of pregnant women has a major role in managing COVID-19 vaccination data of pregnant women and can be one of the Ministry of Health and Medical Education priorities.
Identifiants
pubmed: 37501112
doi: 10.1186/s12884-023-05856-3
pii: 10.1186/s12884-023-05856-3
pmc: PMC10375670
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
542Informations de copyright
© 2023. The Author(s).
Références
Med Pharm Rep. 2019 Jan;92(1):7-14
pubmed: 30957080
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
Life (Basel). 2020 Dec 04;10(12):
pubmed: 33291615
N Engl J Med. 2021 Jun 17;384(24):2273-2282
pubmed: 33882218
Ann Thorac Surg. 2019 Jul;108(1):274-282
pubmed: 30742816
Pharmaceut Med. 2020 Jun;34(3):185-190
pubmed: 32215853
Value Health. 2022 Aug;25(8):1390-1398
pubmed: 35277336
Viruses. 2021 Aug 05;13(8):
pubmed: 34452410
Biomed Res Int. 2021 Aug 22;2021:9942873
pubmed: 34458373
J Clin Epidemiol. 2016 Dec;80:16-24
pubmed: 27555082
Am J Obstet Gynecol. 2021 May;224(5):470-478
pubmed: 33539825
Drug Saf. 2023 Mar;46(3):297-308
pubmed: 36682012
Biomed Res Int. 2019 Jul 7;2019:2936264
pubmed: 31360709
Afr J Prim Health Care Fam Med. 2021 Jul 27;13(1):e1-e3
pubmed: 34342475
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647
pubmed: 33151921
Iran J Pharm Res. 2022 Sep 26;21(1):e130124
pubmed: 36937211
J Community Health. 2022 Oct;47(5):871-878
pubmed: 35841461
J Med Life. 2019 Jan-Mar;12(1):56-64
pubmed: 31123526
PLoS One. 2022 Sep 28;17(9):e0272273
pubmed: 36170334
Womens Health Issues. 2019 Jul - Aug;29(4):341-348
pubmed: 31186144
Vaccines (Basel). 2022 Feb 06;10(2):
pubmed: 35214704
Clin Pharmacol Ther. 2019 Jul;106(1):39-42
pubmed: 30970160
J Obstet Gynaecol Res. 2021 Jun;47(6):1958-1964
pubmed: 33754418
Vaccine. 2021 Oct 1;39(41):6095-6103
pubmed: 34507857
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17
pubmed: 33775692
Am J Obstet Gynecol. 2022 Apr;226(4):459-474
pubmed: 34774821
BMC Health Serv Res. 2018 Apr 11;18(1):279
pubmed: 29642929
Obstet Gynecol. 2018 Jun;131(6):e214-e217
pubmed: 29794683
JAMA. 2021 Oct 26;326(16):1629-1631
pubmed: 34495304
Clin Exp Vaccine Res. 2021 May;10(2):154-170
pubmed: 34222129
BMC Med Inform Decis Mak. 2018 Mar 22;18(Suppl 1):15
pubmed: 29589572
PLoS One. 2020 Aug 20;15(8):e0237903
pubmed: 32817689
Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S24-S31
pubmed: 33977298
Int J Environ Res Public Health. 2018 Aug 03;15(8):
pubmed: 30081484
BMC Med. 2020 Oct 19;18(1):330
pubmed: 33070775
Ther Adv Drug Saf. 2021 Jun 14;12:20420986211021233
pubmed: 34178302
Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S17-S23
pubmed: 34021332
Physiol Rev. 2021 Jan 1;101(1):303-318
pubmed: 32969772
Int J Environ Res Public Health. 2021 May 24;18(11):
pubmed: 34074005